NeoGenomics (NEO) Reports In-Line Q3 EPS

NeoGenomics (NASDAQ: NEO) reported Q3 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $22.43 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Sharon AI secures six-year compute deal with NVIDIA for Australia deployment
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist